Volatile Anesthetics in Cardiac Protection

• Status: Recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Patients undergoing stenting procedures, or cardiac or non-cardiac surgery could develop myocardial damage as testified by cardiac troponin release.

Sevoflurane (volatile anesthetic), routinely used in cardiac and non-cardiac anesthesia, has cardioprotective properties that could be useful to reduce cardiac damage, as indicated by cardiac troponin release in different contexts:

• stenting procedures (periprocedural administration)

• non-cardiac surgery (during the whole procedure)

• cardiac surgery (during the whole procedure)

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Università Vita-Salute San Raffaele
• Treatments: Anesthetics; Sevoflurane

Criteria

Inclusion Criteria:

• Cardiac surgery

• Non-cardiac surgery

• Stenting procedures

Exclusion Criteria:

• Age < 18 years old

• Not signing written consent